Literature DB >> 29315362

Oseltamivir Treatment of Influenza in Children.

Timothy M Uyeki1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29315362      PMCID: PMC6669028          DOI: 10.1093/cid/cix1150

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  30 in total

Review 1.  End points for testing influenza antiviral treatments for patients at high risk of severe and life-threatening disease.

Authors:  Michael G Ison; Menno D de Jong; Kevin J Gilligan; Elizabeth S Higgs; Andrew T Pavia; Jerome Pierson; Frederick G Hayden
Journal:  J Infect Dis       Date:  2010-06-01       Impact factor: 5.226

2.  Use of influenza antiviral medications among outpatients at high risk for influenza-associated complications during the 2013-2014 influenza season.

Authors:  Fiona Havers; Brendan Flannery; Jessie R Clippard; Manjusha Gaglani; Richard K Zimmerman; Lisa A Jackson; Joshua G Petrie; Huong Q McLean; Mary Patricia Nowalk; Michael L Jackson; Arnold S Monto; Edward A Belongia; Heather F Eng; Lois Lamerato; Angela P Campbell; Alicia M Fry
Journal:  Clin Infect Dis       Date:  2015-02-25       Impact factor: 9.079

3.  Limited and Variable Use of Antivirals for Children Hospitalized With Influenza.

Authors:  Chris Stockmann; Carrie L Byington; Andrew T Pavia; Krow Ampofo; Jacob Wilkes; E Kent Korgenski; Adam L Hersh
Journal:  JAMA Pediatr       Date:  2017-03-01       Impact factor: 16.193

4.  The burden of influenza in young children, 2004-2009.

Authors:  Katherine A Poehling; Kathryn M Edwards; Marie R Griffin; Peter G Szilagyi; Mary A Staat; Marika K Iwane; Beverly M Snively; Cynthia K Suerken; Caroline B Hall; Geoffrey A Weinberg; Sandra S Chaves; Yuwei Zhu; Monica M McNeal; Carolyn B Bridges
Journal:  Pediatrics       Date:  2013-01-06       Impact factor: 7.124

5.  Influenza-related hospitalization and ED visits in children less than 5 years: 2000-2011.

Authors:  Astride Jules; Carlos G Grijalva; Yuwei Zhu; H Keipp Talbot; John V Williams; Katherine A Poehling; Sandra S Chaves; Kathryn M Edwards; William Schaffner; David K Shay; Marie R Griffin
Journal:  Pediatrics       Date:  2014-12-08       Impact factor: 7.124

6.  Oral oseltamivir improves pulmonary function and reduces exacerbation frequency for influenza-infected children with asthma.

Authors:  Sebastian L Johnston; Fernando Ferrero; Maria Luz Garcia; Regina Dutkowski
Journal:  Pediatr Infect Dis J       Date:  2005-03       Impact factor: 2.129

7.  A randomized, double-blind, placebo-controlled trial evaluating the safety of early oseltamivir treatment among children 0-9 years of age hospitalized with influenza in El Salvador and Panama.

Authors:  Fatimah S Dawood; Jorge Jara; Rosalba Gonzalez; Juan Miguel Castillo; Tirza De León; Dora Estripeaut; Kathia Luciani; Yarisa Sujey Brizuela; Alfredo Barahona; Rafael Antonio Cazares; Aracelis M Lawson; Mariana Rodriguez; Dinora de Viana; Danilo Franco; Marlene Castillo; Alicia M Fry; Larisa Gubareva; Daisuke Tamura; Michael Hughes; Paul Gargiullo; Wilfrido Clara; Eduardo Azziz-Baumgartner; Marc-Alain Widdowson
Journal:  Antiviral Res       Date:  2016-07-21       Impact factor: 5.970

8.  Estimates of global seasonal influenza-associated respiratory mortality: a modelling study.

Authors:  A Danielle Iuliano; Katherine M Roguski; Howard H Chang; David J Muscatello; Rakhee Palekar; Stefano Tempia; Cheryl Cohen; Jon Michael Gran; Dena Schanzer; Benjamin J Cowling; Peng Wu; Jan Kyncl; Li Wei Ang; Minah Park; Monika Redlberger-Fritz; Hongjie Yu; Laura Espenhain; Anand Krishnan; Gideon Emukule; Liselotte van Asten; Susana Pereira da Silva; Suchunya Aungkulanon; Udo Buchholz; Marc-Alain Widdowson; Joseph S Bresee
Journal:  Lancet       Date:  2017-12-14       Impact factor: 79.321

Review 9.  Neuraminidase inhibitors for preventing and treating influenza in adults and children.

Authors:  Tom Jefferson; Mark A Jones; Peter Doshi; Chris B Del Mar; Rokuro Hama; Matthew J Thompson; Elizabeth A Spencer; Igho Onakpoya; Kamal R Mahtani; David Nunan; Jeremy Howick; Carl J Heneghan
Journal:  Cochrane Database Syst Rev       Date:  2014-04-10

Review 10.  Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data.

Authors:  Stella G Muthuri; Sudhir Venkatesan; Puja R Myles; Jo Leonardi-Bee; Tarig S A Al Khuwaitir; Adbullah Al Mamun; Ashish P Anovadiya; Eduardo Azziz-Baumgartner; Clarisa Báez; Matteo Bassetti; Bojana Beovic; Barbara Bertisch; Isabelle Bonmarin; Robert Booy; Victor H Borja-Aburto; Heinz Burgmann; Bin Cao; Jordi Carratala; Justin T Denholm; Samuel R Dominguez; Pericles A D Duarte; Gal Dubnov-Raz; Marcela Echavarria; Sergio Fanella; Zhancheng Gao; Patrick Gérardin; Maddalena Giannella; Sophie Gubbels; Jethro Herberg; Anjarath L Higuera Iglesias; Peter H Hoger; Xiaoyun Hu; Quazi T Islam; Mirela F Jiménez; Amr Kandeel; Gerben Keijzers; Hossein Khalili; Marian Knight; Koichiro Kudo; Gabriela Kusznierz; Ilija Kuzman; Arthur M C Kwan; Idriss Lahlou Amine; Eduard Langenegger; Kamran B Lankarani; Yee-Sin Leo; Rita Linko; Pei Liu; Faris Madanat; Elga Mayo-Montero; Allison McGeer; Ziad Memish; Gokhan Metan; Auksė Mickiene; Dragan Mikić; Kristin G I Mohn; Ahmadreza Moradi; Pagbajabyn Nymadawa; Maria E Oliva; Mehpare Ozkan; Dhruv Parekh; Mical Paul; Fernando P Polack; Barbara A Rath; Alejandro H Rodríguez; Elena B Sarrouf; Anna C Seale; Bunyamin Sertogullarindan; Marilda M Siqueira; Joanna Skręt-Magierło; Frank Stephan; Ewa Talarek; Julian W Tang; Kelvin K W To; Antoni Torres; Selda H Törün; Dat Tran; Timothy M Uyeki; Annelies Van Zwol; Wendy Vaudry; Tjasa Vidmar; Renata T C Yokota; Paul Zarogoulidis; Jonathan S Nguyen-Van-Tam
Journal:  Lancet Respir Med       Date:  2014-03-19       Impact factor: 30.700

View more
  6 in total

1.  Association of Early Oseltamivir With Improved Outcomes in Hospitalized Children With Influenza, 2007-2020.

Authors:  Patrick S Walsh; David Schnadower; Yin Zhang; Sriram Ramgopal; Samir S Shah; Paria M Wilson
Journal:  JAMA Pediatr       Date:  2022-09-19       Impact factor: 26.796

Review 2.  An overview of key potential therapeutic strategies for combat in the COVID-19 battle.

Authors:  Gaurav Das; Surojit Ghosh; Shubham Garg; Satyajit Ghosh; Aniket Jana; Ramkamal Samat; Nabanita Mukherjee; Rajsekhar Roy; Surajit Ghosh
Journal:  RSC Adv       Date:  2020-07-28       Impact factor: 4.036

Review 3.  Potential therapeutic targets for combating SARS-CoV-2: Drug repurposing, clinical trials and recent advancements.

Authors:  Abhjieet Pandey; Ajinkya Nitin Nikam; Ajjappla Basavaraj Shreya; Sadhana P Mutalik; Divya Gopalan; Sanjay Kulkarni; Bharath Singh Padya; Gasper Fernandes; Srinivas Mutalik; Ruth Prassl
Journal:  Life Sci       Date:  2020-06-01       Impact factor: 5.037

4.  Delayed Influenza Treatment in Children With False-Negative Rapid Antigen Test: A Retrospective Single-Center Study in Korea 2016-2019.

Authors:  Ji Young Lee; Seung Hwan Baek; Jong Gyun Ahn; Seo Hee Yoon; Moon Kyu Kim; Soo Yeon Kim; Kyung Won Kim; Myung Hyun Sohn; Ji-Man Kang
Journal:  J Korean Med Sci       Date:  2022-01-03       Impact factor: 2.153

Review 5.  Coronavirus COVID- 19: A critical review of its history, pathogenesis, transmission, diagnosis and treatment.

Authors:  Mohd Sharjeel Sofi; Aadil Hamid; Sami Ullah Bhat
Journal:  Biosaf Health       Date:  2020-11-08

Review 6.  What are the drugs having potential against COVID-19?

Authors:  Kaan Kucukoglu; Nagihan Faydalı; Dilek Bul
Journal:  Med Chem Res       Date:  2020-09-10       Impact factor: 1.965

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.